NR3C1 and neoplasm: Our comprehensive scRNA-seq analysis of tumour-infiltrating immune cells from TNBC patients highlighted NR3C1 as the dominant steroid receptor gene (Fig. 3A), a finding that is consistent with data from our TNBC mouse model (Supplementary Fig. 3A).